Position in NTLA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,227,258
+$1,018,741 QoQ
Shares Held
72,533
+345.9% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Scientech Research LLC holds $15,218,691 across 44 Biotechnology names. NTLA ranks #4 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
26,826 | $1,878,624 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
12,943 | $1,484,173 | |
| 3 | ABSI |
Absci Corp
|
124,434 | $1,442,190 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
This page
|
72,533 | $1,227,258 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
3,378 | $1,130,920 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
15,341 | $843,755 | |
| 7 | DRTS |
Alpha Tau Medical Ltd.
|
45,752 | $575,560 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
14,456 | $563,928 |
All Filings in NTLA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,227,258 | 72,533 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $208,517 | 16,265 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $166,908 | 18,566 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $485,062 | 28,087 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $806,834 | 39,262 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,054,120 | 47,101 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $556,169 | 20,217 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $318,346 | 10,441 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||